Purdue Pharma L.P.

Track this case

Case overview

Case Number:

7:19-bk-23649

Court:

New York Southern

Nature of Suit:

Firms

Companies

Government Agencies

Sectors & Industries:

October 28, 2024
5 Things About The Quest For Sacklers' Billions Overseas

Many uncertainties hang over the long-running saga of bankrupt opioid maker Purdue Pharma LP. One of the biggest, for creditors, is how to handle the Sackler family that owns the company — or more specifically — their billions of dollars held overseas.
October 23, 2024
Purdue Seeks Another Extension Of Mediation On New Plan

OxyContin maker Purdue Pharma is asking a New York bankruptcy judge for another month to try to work out a replacement for its Chapter 11 plan and opioid settlement that were shot down by the U.S. Supreme Court in June.
October 21, 2024
Purdue Opioid Victims Group Backs Creditors In Litigation Bid

A group of more than 60,000 victims is backing creditors of Purdue Pharma LP in their efforts to potentially sue members of the Sackler family who own the bankrupt opioid maker, and has also warned against protracted legal battles if current mediation efforts fail.
October 15, 2024
Sacklers Say Opioid Claims Can't Undo Purdue Transfers

The family that owns bankrupt drugmaker Purdue Pharma LP is challenging an effort by creditors to claw back billions of dollars transferred by the company to Sackler trusts, telling a New York federal judge that opioid claims fail and can't be used to prove that Purdue made the distributions knowing it was insolvent.
September 30, 2024
J&J Fights For Ch. 11 Venue, NY Diocese Settles For $323M

Johnson & Johnson and the Justice Department are set to face off in a dispute over whether the consumer products giant was justified in putting a talc unit into bankruptcy in Texas this month, after the U.S. Trustee's Office accused J&J of "forum-shopping" its third Chapter 11 filing.
September 23, 2024
Purdue Gets 35 More Days To Mediate New Ch. 11 Deal

Bankrupt OxyContin maker Purdue Pharma LP on Monday won its latest extension to mediate a new settlement with creditors, while also shielding Sackler family members who own the company from lawsuits, after its previous deal was scuttled by the U.S. Supreme Court in June.
September 05, 2024
Purdue Gets Mediation, Injunction Extension In Ch. 11

OxyContin maker Purdue Pharma LP received bankruptcy court approval on Thursday to extend its ongoing mediation for another 18 days and to continue the litigation shield protecting the Sackler family members who own the company, as parties seek consensus on a new Chapter 11 plan structure.
July 15, 2024
Giuliani Booted, Purdue Regroups, Redbox Pivots

Rudy Giuliani's Chapter 11 case was tossed for his lack of financial disclosures, Purdue Pharma pressed for renewed plan mediation as creditors hedged their bets by seeking permission to sue its owners, and the parent company of Redbox pivoted to a liquidation due to what it described as mismanagement of the business.
July 09, 2024
Purdue Plans 'High-Speed' Bid For New Ch. 11 Plan

Purdue Pharma told a New York bankruptcy judge Tuesday that it plans a two-month "high-speed, high-stakes" attempt to replace the Chapter 11 plan shot down by the U.S. Supreme Court last month before unleashing litigation on its former owning family.
July 08, 2024
Purdue Creditors Look To Sue Sacklers After Justices' Ruling

The official committee of unsecured creditors in the Chapter 11 case of drugmaker Purdue Pharma asked a New York bankruptcy judge on Monday for standing to bring actions against members of the Sackler family that own the company after the U.S. Supreme Court torpedoed a precarious settlement among the parties.

← Previous
1
2
3
4
5
6
7
8
9
10
…
Next →